💊FDA PHARMA today

💊FDA PHARMA today

Ultragenyx和Kyowa Kirin宣布Burosumab接受积极的CHMP治疗儿童X连锁低磷酸盐血症的意见

http://www.kyowa-kirin.com/news_releases/2017/pdf/e20171215_01.pdf

武田和TiGenix宣布Cx601（darvadstrocel）收到了CHMP的积极意见，用于治疗克罗恩病中复杂的肛周瘘

https://www.takeda.com/newsroom/newsreleases/2017/takeda-and-tigenix-announce-that-cx601-darvadstrocel-has-received-a-positive-chmp-opinion-to-treat-complex-perianal-fistulas-in-crohns-disease/